Screener
Emergent Biosolutions EBS Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on trailing twelve months.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
FAQ
- What is Emergent Biosolutions's asset turnover?
- Emergent Biosolutions (EBS) reported asset turnover of 0.6× in Q2 2026.
- How has Emergent Biosolutions's asset turnover changed year-over-year?
- Emergent Biosolutions's asset turnover increased by 4.6% year-over-year, from 0.6× to 0.6×.
- What is the long-term trend for Emergent Biosolutions's asset turnover?
- Over 5 years (2020 to 2025), Emergent Biosolutions's asset turnover has grown at a -1.7% compound annual growth rate (CAGR), from 0.6× to 0.5×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Emergent Biosolutions's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude